Home/Pipeline/Generic Drug Portfolio Development

Generic Drug Portfolio Development

Various (e.g., Oncology, Dermatology)

Approved/CommercialActive

Key Facts

Indication
Various (e.g., Oncology, Dermatology)
Phase
Approved/Commercial
Status
Active
Company

About Deva Holdings

Deva Holdings is a major, publicly traded Turkish pharmaceutical manufacturer with a 65+ year history, specializing in generic drugs, APIs, and consumer health products. It operates three production facilities and a logistics center in Turkey, with a growing international footprint. The company's strategy centers on generic drug development, with R&D efforts in pharmaceutical technology and biotechnology, aiming to be a leader in equivalent drug development.

View full company profile